ES2008670B3 - Un procedimiento para preparar un derivado del ester guanidinobenzoicoy compuestos farmaceuticos que lo contienen. - Google Patents

Un procedimiento para preparar un derivado del ester guanidinobenzoicoy compuestos farmaceuticos que lo contienen.

Info

Publication number
ES2008670B3
ES2008670B3 ES86117885T ES86117885T ES2008670B3 ES 2008670 B3 ES2008670 B3 ES 2008670B3 ES 86117885 T ES86117885 T ES 86117885T ES 86117885 T ES86117885 T ES 86117885T ES 2008670 B3 ES2008670 B3 ES 2008670B3
Authority
ES
Spain
Prior art keywords
formula
preparing
derivative
guanidinobenzoico
ester
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES86117885T
Other languages
English (en)
Inventor
Takashi Yamanaka
Tsutomu Kawata
Naoyuki Shimomura
Shuhei Miyazawa
Junsaku Nagaoka
Naoko Nagaoka
Ieharu Hishinuma
Shigeru Souda
Kaname Miyamoto
Hidetoshi Kawashima
Tsuneo Wakabayashi
Junichi Nagakawa
Norihiro Ueda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai Co Ltd
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Application granted granted Critical
Publication of ES2008670B3 publication Critical patent/ES2008670B3/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/14—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C07D207/40—2,5-Pyrrolidine-diones
    • C07D207/404—2,5-Pyrrolidine-diones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. succinimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/16—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/10—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C323/18—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
    • C07C323/20—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton with singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/44—Two oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyrrole Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

Procedimiento para la fabricación de derivados del éster guanidinobenzoico o sales farmacéuticamente aceptables del mismo, de fórmula general: *** (Fórmula) *** en la que X representa un grupo de fórmula: *** (Fórmula) *** en el cual Y es un grupo de fórmula: - (CH2)m - , siendo m un entero de valor 2 ó 3, *** (Fórmula) *** o bien un grupo de fórmula: - OR en el cual R es un átomo de hidrógeno o un grupo alquilo inferior y n representa un entero de valor comprendido entre 1 y 5, caracterizado por la esterificación del ácido guanidinobenzoico de fórmula: *** (Fórmula) *** con un compuestodef ormula general *** (Fórmula) *** en el que X representa un grupo de fórmula: *** (Fórmula) *** en el cual Y es un grupo de fórmula: - (CH2)m - , siendo m un entero de valor 2 ó 3, *** (Fórmula) *** o un grupo de fórmula: - OR en el cual R es un átomo de hidrógeno o un grupo alquilo inferior y n representa un entero comprendido entre 1 y 5, para formar un derivado del éster guanidinobenzoico de fórmula general: *** (Fórmula) *** en las que n y X son los definidos anteriormente, y, si es necesario, convirtiendo el derivado obtenido de este modo en una sal farmacológicamente aceptable del mismo.
ES86117885T 1985-12-27 1986-12-22 Un procedimiento para preparar un derivado del ester guanidinobenzoicoy compuestos farmaceuticos que lo contienen. Expired ES2008670B3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60293268A JPH0676373B2 (ja) 1985-12-27 1985-12-27 グアニジノ安息香酸エステル誘導体

Publications (1)

Publication Number Publication Date
ES2008670B3 true ES2008670B3 (es) 1989-08-01

Family

ID=17792620

Family Applications (1)

Application Number Title Priority Date Filing Date
ES86117885T Expired ES2008670B3 (es) 1985-12-27 1986-12-22 Un procedimiento para preparar un derivado del ester guanidinobenzoicoy compuestos farmaceuticos que lo contienen.

Country Status (13)

Country Link
US (3) US4801603A (es)
EP (1) EP0229370B1 (es)
JP (1) JPH0676373B2 (es)
KR (1) KR910009980B1 (es)
AT (1) ATE42279T1 (es)
AU (1) AU583970B2 (es)
CA (1) CA1277669C (es)
DE (1) DE3662883D1 (es)
DK (1) DK623486A (es)
ES (1) ES2008670B3 (es)
HU (1) HU197878B (es)
NZ (1) NZ218617A (es)
PH (1) PH25377A (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4808696A (en) * 1987-06-01 1989-02-28 General Electric Company Method for making organobis(thioether)s, and products obtained therefrom
US5238964A (en) * 1990-04-05 1993-08-24 Torii & Co., Ltd. Agent for treatment of cerebrovascular contraction
JPH078789B2 (ja) * 1990-04-05 1995-02-01 鳥居薬品株式会社 脳血管攣縮治療剤
FR2691146B1 (fr) * 1992-05-15 1998-01-02 Adir Nouveaux derives d'acides alcenecarboxyliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
EP0893437A4 (en) 1996-04-10 2000-12-27 Ono Pharmaceutical Co GUANIDINO TRYPTASE INHIBITOR
US5968795A (en) * 1996-05-15 1999-10-19 Bayer Corporation Biaryl acetylenes as inhibitors of matrix metalloproteases
WO1998005333A1 (en) * 1996-08-05 1998-02-12 Molecumetics Ltd. Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors
EP1661566A3 (en) * 1996-08-05 2008-04-16 Myriad Genetics, Inc. Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors
US6066673A (en) * 1998-03-12 2000-05-23 The Procter & Gamble Company Enzyme inhibitors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1905813A1 (de) * 1968-07-04 1970-03-05 Akad Wissenschaften Ddr 3- oder 4-Guanidobenzoesaeurebenzyl- oder -phenylestern und deren Verwendung als Inhibitoren
IL41159A (en) * 1972-01-12 1976-02-29 Ciba Geigy Ag Dichloromaleic acid imides,their preparation and their use in the control of plant pathogenic fungi
GB1472700A (en) * 1974-11-01 1977-05-04 Ono Pharmaceutical Co Guanidinobehzoic acid derivatives and process for preparing the same
JPS5470241A (en) * 1977-11-09 1979-06-05 Ono Pharmaceut Co Ltd Guanidinobenzoic acid derivative and its preparation
GB2044760B (en) * 1979-03-01 1983-03-23 Ono Pharmaceutical Co Guanidinobenzoic acid derivatives
FR2456731A1 (fr) * 1979-05-16 1980-12-12 Choay Sa Nouveaux derives substitues d'ary
JPS5634662A (en) * 1979-08-31 1981-04-06 Ono Pharmaceut Co Ltd Guanidinobenzoic acid derivative and its preparation

Also Published As

Publication number Publication date
NZ218617A (en) 1989-02-24
DK623486D0 (da) 1986-12-22
EP0229370A1 (en) 1987-07-22
JPH0676373B2 (ja) 1994-09-28
DK623486A (da) 1987-06-28
CA1277669C (en) 1990-12-11
ATE42279T1 (de) 1989-05-15
KR910009980B1 (ko) 1991-12-09
US4801603A (en) 1989-01-31
PH25377A (en) 1991-06-03
AU6690586A (en) 1987-07-02
JPS62155253A (ja) 1987-07-10
HU197878B (en) 1989-06-28
US4948808A (en) 1990-08-14
HUT43809A (en) 1987-12-28
US5075335A (en) 1991-12-24
AU583970B2 (en) 1989-05-11
EP0229370B1 (en) 1989-04-19
KR870005985A (ko) 1987-07-08
DE3662883D1 (en) 1989-05-24

Similar Documents

Publication Publication Date Title
DK165004C (da) Sulfamatderivater og farmaceutiske praeparater indeholdende disse
FI930991A0 (fi) Polymerer som innehaoller diesterenheter
DK599785D0 (da) Blokpolyestere og detergentkompositioner indeholdende disse
EP0322182A3 (en) Azabicyclic compounds, process for their preparation and pharmaceutical compositions containing them
DE59103664D1 (de) Verfahren zur Inhibierung und Zerstörung von Peroxiden in Dialkylethern.
HU906284D0 (en) Process for the production of 24-homo-d-vitamin derivatives and medical preparations containing them as active agents
DE59002863D1 (de) Lysolecithinderivate zur behandlung von autoimmunerkrankungen.
ES2008670B3 (es) Un procedimiento para preparar un derivado del ester guanidinobenzoicoy compuestos farmaceuticos que lo contienen.
GR3001441T3 (en) Pyrrolidinylamide ester derivative having anti-prolyl endopeptidase activity, its synthesis and use and a pharmaceutical composition containing it
DE3875346D1 (de) Zusammensetzungen, die mit 1-oxo- oder thiokohlenwassserstoff substituierte azacycloalkane enthalten.
MXPA03000547A (es) Uso de derivados de amidas de acido valproico y de acido 2-valproenico, para el tratamiento de manias en trastornos bipolares.
MX9703339A (es) Solucion acuosa para infusion, estable al almacenamiento, que contiene un inhibidor de trombina.
ATE66475T1 (de) Aromatische thioaether.
EP0402469A4 (en) Catechol compounds, process for their preparation and pharmaceutical preparation containing same
SE8204791D0 (sv) Process for preparing alkoxy-vincaminic acid esters and alkoxy-apovincaminic acid esters
ES2002427A6 (es) Procedimient para la preparacion de nuevos analogos de gonadoliberina
DE59305822D1 (de) Verwendung von prostanderivaten zur herstellung eines arzneimittels zur behandlung der chronischen polyarthritis
HRP940443B1 (en) Process for the preparation of 1-nitro-2,2-diaminoethylene derivatives
JPS56161380A (en) Piperazine derivative, its preparation and medicine containing the same as active constituent